RECORDATI : POSITIVE CONCLUSION TO THE DECENTRALIZED PROCEDURE FOR THE APPROVAL IN EUROPE OF PITAVASTATIN (LIVAZO(R))
companynewsgroup Home Page
Return to Release | Remove Frame